共 71 条
[1]
Bauer JA(2010)Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation Clin Cancer Res 16 681-690
[2]
Chakravarthy AB(2023)Crosstalk between microtubule stabilizing agents and prostate cancer Cancers 15 3308-7701
[3]
Rosenbluth JM(2013)Predictive and prognostic values of Tau and BubR1 protein in prostate cancer and their relationship to the Gleason score Med Oncol 30 526-2115
[4]
Chen Q-H(2023)Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells J Cancer Res Clin Oncol 149 7689-714
[5]
Cirak Y(2005)The MAP2/Tau family of microtubule-associated proteins Genome Biol 6 204-128
[6]
Sarsik B(2001)Expression of microtubule-associated protein 2 in benign and malignant melanocytes Am J Pathol 158 2107-7441
[7]
Cakar B(2009)Differential expression of microtubule-associated protein 2 in melanocytic skin lesions Am J Clin Pathol 131 710-813
[8]
Clementi L(1966)Classification of prostatic carcinomas Cancer Chemother Rep 50 125-329
[9]
Sabetta S(2012)Gene expression and pathologic response to neoadjuvant chemotherapy in breast cancer Mol Biol Rep 39 7435-106
[10]
Zelli V(2019)EAU-EANM-ESTRO-ESUR-SIOG prostate cancer guideline panel consensus statements for deferred treatment with curative intent for localised prostate cancer from an international collaborative study (DETECTIVE Study) Eur Urol 76 790-721